therefore decided to vary the depth of injection to test whether this uneven distribution was merely a reflection of the site of injection or was, in fact, a preferential uptake. The choline was injected at the same point of entry as before but the distance from the surface varied from 1.5 to 4mm. After an exchange time of 0.5h the total radioactivity in the brain was slightly higher after the shallower injections than after those at 4mm. The distribution of radioactivity among the regions was very different from that found after the injections at 4mm. For example, after the injection at 1.5mm the percentage of the recovered activity in the hypothalamus was only 8 % compared with 29 % after that at 4mm. However, the cortex contained 35 % compared with 14% after the injection at 4mm. It is noteworthy that the percentage distribution in the midbrain was almost unaffected by the depth of injection.
It had been found previously (Ansell & Spanner, 1968 ) that there was a very rapid phosphorylation of choline after intraventricular injection. This was borne out when the individual regions were examined, each region showing a high percentage of labelling in the phosphorylcholine after 0.5-4.0h of exchange. However, when the labelled choline was injected into the brain tissue above the ventricle there was a very considerable depression of the phosphorylation, i.e. to an average of 15 % after the injection at 1 Smm and of 19.5 % after the injection at 3.0mm compared with over 75 % after that at 4mm.
The distribution of choline kinase activity when measured in vitro showed little variation from region to region (Table l), so that the reason for this discrepency has yet to be explained. The ratio of the specific radioactivity of phosphatidylcholine to that of phosphorylcholine in vivo was unaffected.
The transfer of the labelled choline and its metabolites from the injected to the uninjected side of the brain was also examined after different depths of injection. The steep gradient found by Carr & Moore (1969) The effect of hemicholinium-3, a drug known to modify choline metabolism, was tried on the system. Although it inhibits the formation of acetylcholine, it does not act on the enzyme choline acetyltransferase (EC 2.3.1.6) (Diamond & Milfay, 1972) . When it was injected with [Me-'4C]choline into the brain in a choline/hemicholinium-3 molar ratio of 1.0: 5.9, we found a stimulation of phosphatidylcholine labelling by the hemicholinium-3 (cf. Gomez et al., 1970) . This stimulation was not found when [32P]Pi was used as the precursor (Rodriguez de Lores Arnaiz e f al., 1970) , so that the effect appears to be directly on the choline moiety. It was also found that hemicholinium-3 caused a much less steep gradient from the injected to the uninjected side of the brain. In this connexion it is noteworthy that Slater & Stonier (1971) found that, when choline and hemicholinium-3 were injected into the left ventricle of the rat brain, the choline caused a levelling off of the left-to-right gradient of hemicholinium-3 concentration and that it was the bound hemicholinium-3 that was affected. In vitro choline kinase activity was found to be markedly depressed by the presence of hemicholinium-3 (Iso = 20pM); a similar effect was found in vivo. Diamond & Kennedy (1969) demonstrated that 850p~-hemicholinium-3 largely inhibited the formation of phosphorylcholine by isolated synaptosomes.
